Roffman Miller Associates Inc Merck & Co., Inc. Transaction History
Roffman Miller Associates Inc
- $1.79 Billion
- Q3 2025
A detailed history of Roffman Miller Associates Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Roffman Miller Associates Inc holds 211,806 shares of MRK stock, worth $19.7 Million. This represents 0.99% of its overall portfolio holdings.
Number of Shares
211,806
Previous 205,225
3.21%
Holding current value
$19.7 Million
Previous $16.2 Million
9.42%
% of portfolio
0.99%
Previous 0.97%
Shares
33 transactions
Others Institutions Holding MRK
# of Institutions
3,877Shares Held
1.9BCall Options Held
31.1MPut Options Held
28.5M-
Vanguard Group Inc Valley Forge, PA252MShares$23.4 Billion0.33% of portfolio
-
Black Rock Inc. New York, NY207MShares$19.2 Billion0.59% of portfolio
-
State Street Corp Boston, MA118MShares$11 Billion0.35% of portfolio
-
Wellington Management Group LLP Boston, MA75.3MShares$6.99 Billion1.16% of portfolio
-
Geode Capital Management, LLC Boston, MA59.8MShares$5.55 Billion0.33% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $235B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...